Alessio Pisa

Catalyst Health Ventures (Catalyst Health Ventures) is a venture capital firm founded in 2008 by Darshana Zaveri and Joshua S Phillips. The firm is Headquartered in Boston, Massachusetts.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA.

AtaCor Medical, Inc. develops cardiac medical devices. The firm offers AtaCor pacing system. The company was founded by Rick Sanghera, Alan Marcovecchio, and Sean McGeehan in 2014 and is headquartered in San Clemente, CA.

Avive Solutions, Inc. operates as a healthcare technology firm. It develops a next generation automated external defibrillator and software solutions to help increase survival rates from Sudden Cardiac Arrest. The company was founded by Rory Beyer, Sameer Jafri, and Moseley Andrews in 2017 and is headquartered in San Francisco, CA.

PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA.

Aria CV, Inc. develops medical devices. It designed to improve the lives of patients living with the disease of pulmonary hypertension. The company was founded by John Scandurra and Karl Vollmers in 20101 and is headquartered in St. Paul, MN.

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

DailyFeats, Inc. engages in the provision of a health-as-a-service platform. It offers an end-to-end operating system for benefits that includes a marketplace, a comprehensive benefits administration system, and a mobile platform where employees access everything benefits-related, navigate the healthcare system, and manage their health and wealth. The company was founded by Veer Gidwaney and Vinay Gidwaney on June 26, 2008 and is headquartered in Boston, MA.

Lantos Technologies, Inc. develops intra-aural 3D ear scanning systems for the custom earpiece market. Its technology enables audiologists to eliminate the uncomfortable, messy, and error-prone technique that used to generate impressions of the ear canal. The firm provides 3D scanner that measures ear canal shape and tissue compliance to produce a map of the ear canal. It also offers noise protection devices for military and industrial markets, and consumer audio earphones. The company is headquartered in Wilmington, MA.

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.